Hypomutable Potential Accompanying Interferon-α Resistance in a Human Cell Line, IFr, Derived from Interferon-αSensitive and Hypermutable RSa Cells

A human cell line, IFr, established from RSa cells, is a variant with increased resistance to cell proliferation inhibition (CPI) by human interferon (HuIFN)-α. The parent RSa cells are also hypermutable after irradiation with far-ultraviolet light (UV), as assessed by two different methods: cloning efficiency of ouabain-resistant (OuaR) mutants and K-ras codon 12 mutation in genomic DNA identified by polymerase chain reaction (PCR) following differential dot-blot hybridization. In the present study, IFr cells were found to be hypomutable: Less than 1 OuaR mutant per 104 surviving cells after UV (0-12 J/m2), in contrast to 1-53 OuaR mutants per 104 survivors in RSa cells, and no-detectable K-ras codon 12 mutation at any doses tested. However, IFr cells, when cultured with medium containing the protease inhibitor antipain after UV irradiation showed hypermutability to almost the same extent as RSa cells, as determined by both phenotypic and genetic mutation analyses. These results, together with the previo...

[1]  N. Suzuki Suppression of UV‐ and interferon‐α‐refractoriness by antipain in human IFr cells established from RSa cells sensitive to both stimuli , 1996, Journal of cellular physiology.

[2]  G. Walker SOS-regulated proteins in translesion DNA synthesis and mutagenesis. , 1995, Trends in biochemical sciences.

[3]  N. Suzuki,et al.  Suppression of Saccharin-induced Mutagenicity by Interferon-α in Human RSa Cells , 1995 .

[4]  N. Suzuki,et al.  Piperonyl butoxide mutagenicity in human RSa cells. , 1995, Mutation research.

[5]  E. Isogai,et al.  Involvement of antipain-sensitive protease activity in suppression of UV-mutagenicity by human interferon-alpha. , 1994, Mutation research.

[6]  J. Yoshida,et al.  Dipyridamole enhances an anti‐proliferative effect of interferon in various types of human tumor cells , 1992, International journal of cancer.

[7]  E. Isogai,et al.  Serum factors responsible for unusual induction of plasminogen activator activity in tuberous sclerosis , 1992, Journal of the Neurological Sciences.

[8]  N. Suzuki,et al.  Suppression of UV mutagenicity by human interferon. , 1988, Mutation research.

[9]  D. Currie,et al.  Inhibition of H-ras oncogene transformation of NIH3T3 cells by protease inhibitors. , 1987, Cancer research.

[10]  N. Suzuki,et al.  Cross-sensitivity between interferon and uv in human cell strains: IFr, HEC-1, and CRL1200. , 1984, Virology.

[11]  N. Suzuki,et al.  A UV-sensitive human clonal cell line, RSa, which has low repair activity. , 1981, Mutation research.

[12]  Y. Kano,et al.  Effects of a tumor promoter and an anti-promoter on spontaneous and UV-induced 6-thioguanine-resistant mutations and sister-chromatid exchanges in V79 Chinese hamster cells. , 1980, Mutation research.

[13]  A. Fuse,et al.  Effects of interferon on cell and virus growth in transformed human cell lines. , 1976, The Journal of general virology.